Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.91089 | 38 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.88541 | 39 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.88075 | 38 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.84778 | 39 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.84545 | 39 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.95774 | 38 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.9414 | 38 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.85265 | 38 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.8611 | 39 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.87802 | 39 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.86667 | 38 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.8712 | 39 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.87093 | 38 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.87379 | 38 |